Editorial: New opportunities in drug design for the management and treatment of type 2 diabetes

Editorial: New opportunities in drug design for the management and treatment of type 2 diabetes

Bibliographic Details
Main Authors:	Hassan Rasouli, Teodorico C. Ramalho, Jelena B. Popović-Djordjević, Hari Prasad Devkota
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-04-01
Series:	Frontiers in Pharmacology
Subjects:	drug design diabetes mellitus type 2 diabetes inhibitor hypoglycemic agents
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1187057/full

Similar Items

Changes in prescription patterns and doses of oral antidiabetic drugs in Japanese patients with type 2 diabetes (JDDM70)
by: Shinichiro Shirabe, et al.
Published: (2023-01-01)

Acarbose Reduces Low-Grade Albuminuria Compared to Metformin in Chinese Patients with Newly Diagnosed Type 2 Diabetes
by: Song L, et al.
Published: (2021-11-01)

Insulin Fact Sheet in Type 1 and 2 Diabetes Mellitus and Trends of Antidiabetic Medication Use in Insulin Users with Type 2 Diabetes Mellitus: 2002 to 2019
by: Jiyun Park, et al.
Published: (2023-03-01)

Potential Hypoglycemic Property of Albiza Myriophylla Benth in Streptozotocin-Nicotinamide Induced Diabetic Rats
by: Sa'at, Azmah
Published: (2011)

Drug-drug Interactions between Hypoglycemic and Non-hypoglycemic Medication in Diabetic Patients with Comorbidities in a Tertiary Care Center: A Descriptive Cross-sectional Study
by: Lujaw Ratna Tuladhar, et al.
Published: (2021-11-01)

Prevalence and predictors of clinical inertia in patients with type 2 diabetes who were treated with a single oral antidiabetic drug
by: Ryo Suzuki, et al.
Published: (2023-01-01)

Diabetes Drugs and Cardiovascular Safety
by: Ji Cheol Bae
Published: (2016-06-01)

Monotherapy in Patients with Type 2 Diabetes Mellitus
by: Sang Youl Rhee, et al.
Published: (2017-10-01)

Pharmacogenetics of hypoglycemic agents
by: Irina Vladimirovna Kononenko, et al.
Published: (2015-12-01)

Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
by: Seung-Hyun Ko, et al.
Published: (2017-10-01)

EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus
by: Gagik Radikovich Galstyan
Published: (2013-06-01)

Association of anti-diabetic drugs and COVID-19 outcomes in patients with diabetes mellitus type 2 and cardiomyopathy
by: Jelena Dimnjaković, et al.
Published: (2024-03-01)

Assessment of Type 2 Diabetes Patients’ Knowledge of Oral Hypoglycemic Agents
by: Milica Paut Kusturica, et al.
Published: (2020-01-01)

Comparative Effect of Glucose-Lowering Drugs for Type 2 Diabetes Mellitus on Stroke Prevention: A Systematic Review and Network Meta-Analysis
by: Ji Soo Kim, et al.
Published: (2024-03-01)

Association Between Fear of Hypoglycemia and Treatment Satisfaction Among Patients With Diabetes Mellitus
by: Hamideh Hakimi, et al.
Published: (2024-01-01)

Empagliflozin-based quadruple oral therapy for type 2 diabetes: a prospective cohort study
by: Fatemeh Moosaie, et al.
Published: (2025-01-01)

Non-Insulin Antidiabetes Treatment in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
by: Xiaoling Cai, et al.
Published: (2021-05-01)

Association between use of oral hypoglycemic agents in Japanese patients with type 2 diabetes mellitus and risk of depression: A retrospective cohort study
by: Hayato Akimoto, et al.
Published: (2019-12-01)

Comparison of Antidiabetic Regimens in Patients with Type 2 Diabetes Uncontrolled by Combination Therapy of Sulfonylurea and Metformin: Results of the MOHAS Disease Registry in Korea
by: Sung Hee Choi, et al.
Published: (2017-05-01)

Comparative pharmacoepidemiological study of antihyperglycemic drugs utilization by patients with type 2 diabetes mellitus in Moscow
by: Marina F. Kalashnikova, et al.
Published: (2016-07-01)

Synthesis of a New Zinc-Mixed Ligand Complex and Evaluation of Its Antidiabetic Properties in High Fat Diet: Low Dose Streptozotocin Induced Diabetic Rats
by: Muruganantham Koothappan, et al.
Published: (2018-04-01)

Effect of Dosage Reduction of Hypoglycemic Multidrug Regimens on the Incidences of Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramaḍān: A Randomized Controlled Trial
by: Louay Y. Zaghlol, et al.
Published: (2021-07-01)

Comparison of SGLT2 inhibitors with DPP-4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
by: Young Sang Lyu, et al.
Published: (2023-07-01)

Antidiabetic Effect of Artemisia deserti Ethanolic Extract in Normal and Streptozotocin-induced Diabetic Rats
by: Akram Eidi
Published: (2014-05-01)

Paradigmas e trajetórias tecnológicas em saúde: desafios da inovação no cuidado da diabetes
by: Jane Mary de Medeiros Guimarães, et al.

Machine Learning Approach to Drug Treatment Strategy for Diabetes Care
by: Kazuya Fujihara, et al.
Published: (2023-05-01)

Hypoglycemic Effect of Betulin in Rats With Experimental Diabetes
by: Agnieszka Zakrzeska, et al.
Published: (2023-11-01)

Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus
by: Min Kyong Moon, et al.
Published: (2017-10-01)

Ethnomedicinal survey of traditional antidiabetic plants in Baturraden and Sumbang
by: Wahyu Utaminingrum, et al.
Published: (2020-08-01)

Effectiveness of triple therapy with dapagliflozin add-on to dual therapy over 52 weeks in patients with uncontrolled type 2 diabetes mellitus in a centre of high complexity, Cali-Colombia
by: Vanessa Bedoya Joaqui, et al.
Published: (2021-01-01)

Medication Adherence to Type 2 Diabetic Patients Hospitalized at a Tertiary Care Hospital in Bangladesh
by: Mohammad Masud Rana, et al.
Published: (2019-12-01)

Determinants of Non-Adherence to Treatment Among Patients with Type 2 Diabetes in Kenya: A Systematic Review
by: Masaba BB, et al.
Published: (2021-01-01)

Factors Associated with Long-Term Oral Hypoglycemic Agent Responsiveness in Korean Patients with Type 2 Diabetes Mellitus
by: Bo-Yeon Kim, et al.
Published: (2011-06-01)

The application of medicinal fungi from the subphylum Ascomycota in the treatment of type 2 diabetes
by: Yingnan Jiang, et al.
Published: (2025-07-01)

Initial Combination Therapy in Type 2 Diabetes
by: Ji Yoon Kim, et al.
Published: (2024-02-01)

Quality of diabetes mellitus therapy in patients with chronic kidney disease in the real world
by: Beatrice Giampietro, et al.
Published: (2017-03-01)

Cognition and drug adherence to oral hypoglycemic and antihypertensive agents in older adults
by: Bakouni H, et al.
Published: (2019-05-01)

Hypoglycaemia in clinical diabetes /
by: Frier, Brian M, et al.
Published: (2007)

EFFECT OF CHLOROQUINE ON BLOOD GLUCOSE LEVELS IN PATIENTS WITH NON INSULIN DEPENDENT DIABETES MELLITUS
by: H. Mostafavi
Published: (1998-08-01)

EFFECT OF CHLOROQUINE ON BLOOD GLUCOSE LEVELS IN PATIENTS WITH NON INSULIN DEPENDENT DIABETES MELLITUS
by: H. Mostafavi
Published: (1998-12-01)